US Stock MarketDetailed Quotes

BLUE bluebird bio

Watchlist
  • 8.350
  • +0.090+1.09%
Close Jan 17 16:00 ET
  • 8.400
  • +0.050+0.60%
Post 19:59 ET
81.18MMarket Cap-0.23P/E (TTM)

About bluebird bio Company

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Company Profile

SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees375
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Obenshain
  • Director, President and Chief Executive Officer
  • 3.05M
  • Thomas J. Klima
  • Chief Commercial and Operating Officer
  • 1.33M
  • Joseph Vittiglio
  • Chief Legal and Business Officer
  • --
  • Richard A. Colvin
  • Chief Medical Officer
  • 1.34M
  • O. James Sterling
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • O. James Sterling
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Mark Vachon
  • Chairman of the Board
  • 200.91K
  • Nick Leschly
  • Director
  • 96.41K
  • Michael Cloonan
  • Director
  • --
  • Dr. John O. Agwunobi, M.D.
  • Independent Director
  • 160.91K
  • Dr. Elisabeth Leiderman, M.D.
  • Independent Director
  • 167.91K
  • Richard Paulson, M.B.A.
  • Independent Director
  • 65.24K
  • Najoh Tita-Reid
  • Independent Director
  • 153.91K
  • Dr. Charlotte Jones-Burton, M.D.,M.S.
  • Independent Director
  • 146.41K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.